SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-16-000028
Filing Date
2016-11-02
Accepted
2016-11-02 15:02:00
Documents
69
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-9302016x10xq.htm 10-Q 1059977
2 EXHIBIT 31.1 pcrx-93016xex311.htm EX-31.1 14791
3 EXHIBIT 31.2 pcrx-93016xex312.htm EX-31.2 14808
4 EXHIBIT 32.1 pcrx-93016xex321.htm EX-32.1 5636
5 EXHIBIT 32.2 pcrx-93016xex322.htm EX-32.2 5544
  Complete submission text file 0001396814-16-000028.txt   5717909

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pcrx-20160930.xml EX-101.INS 1205768
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20160930.xsd EX-101.SCH 42977
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20160930_cal.xml EX-101.CAL 67949
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20160930_def.xml EX-101.DEF 187007
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20160930_lab.xml EX-101.LAB 612049
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20160930_pre.xml EX-101.PRE 329790
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 161967555
SIC: 2834 Pharmaceutical Preparations